PTPRC and B-cell non-Hodgkin lymphoma: Second, staining with the diagnostic B-cell marker B220 indicates that the CAG-A3B mice are developing predominantly B-cell lymphomas, either de novo or from preceding lymphoid hyperplasias (Figures 4F and S5A-B).